Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG - World Stem Cell Summit

European first as County Durham stroke patient, 28, takes part in stem cell treatment trial

by admin | Sep 27, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Helen Ford – Health Correspondent, ITV News Tyne Tees A young patient from County Durham is the first in Europe to take part in a new trial to discover whether stem cell treatment can improve recovery from strokes. Harrison Kingsley, 28, suffered a serious...

Judge tosses FDA lawsuit targeting a clinic offering unproven stem cell treatments

by admin | Sep 26, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

By Michael Hiltzik | Business Columnist | Los Angeles Times A federal judge in Riverside declared a California stem cell treatment firm to be exempt from Food and Drug Administration regulations, opening the door to the further proliferation of clinics offering...

A breakthrough for fast, efficient production of human immune cells

by admin | Sep 26, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by University of British Columbia A University of British Columbia research team has developed a new, fast, efficient process for producing cancer-fighting immune cells in the lab. The discovery could help transform the field of immune cell therapy from an expensive,...

Common Viruses May Be Triggering the Onset of Alzheimer’s Disease

by admin | Sep 21, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

Shingles infection may activate dormant neurological herpes viruses, causing inflammation and accumulation of Alzheimer’s associated proteins in the brain by Mike Silver – TuftsNow Alzheimer’s disease can begin almost imperceptibly, often masquerading in the...

After last year’s public rejection, BrainStorm to give ALS cell therapy another shot

by admin | Sep 20, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Tyler Patchen and Kyle LaHucik – EndpointsNews Above image caption: Chaim Lebovits, BrainStorm CEO After a rare public rejection from the FDA last year, BrainStorm Cell Therapeutics is headed back to the regulator with what it claims is a “correction” to...

A research partnership brings gene editing promise to eye disease

by admin | Sep 19, 2022 | Bernie Siegel’s WORLD STEM CELL SUMMIT BLOG, News and Opinions

by Brian Mattmiller In order to tap the tremendous potential of CRISPR gene editing technology for reversing human disease, Wisconsin scientists are working with a star pupil. The human eye — though one of the body’s most complex and intricate structures — happens to...